mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.27 |
0.03 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |